載入...
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the developed world and is associated with a fivefold increase in the risk of stroke, accounting for up to 15% of strokes in the general population. The European Society of Cardiology now recommends direct oral anticoagulants, such as...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3968084/ https://ncbi.nlm.nih.gov/pubmed/24711702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S30159 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|